Caricamento...
Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
PURPOSE: Two new drugs with mucin-inducing and secretion-promotive effects, rebamipide and diquafosol, were recently approved as topical dry-eye treatments. We report two cases in which the long-term use of mucin-inducing eye drops improved chronic ocular graft-versus-host disease (cGVHD)–related dr...
Salvato in:
| Pubblicato in: | Optom Vis Sci |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4376271/ https://ncbi.nlm.nih.gov/pubmed/25785527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/OPX.0000000000000523 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|